Health Care & Life Sciences » Biotechnology | OncoTherapy Science Inc.

OncoTherapy Science Inc.

OncoTherapy Science Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY19.9
Market Cap
JPY17.48 B
Shares Outstanding
154.99 M
Public Float
111.76 M

Profile

Address
Kanagawa Science Park R&D D Bldg.
Kawasaki Kanagawa 213
Japan
Employees -
Website http://www.oncotherapy.co.jp
Updated 07/08/2019
OncoTherapy Science, Inc. engages in the research and development of pharmaceutical products. It focuses its research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan.

Financials

View All

Kazuo Yamamoto
President & Representative Director
Takahiro Mori
Director & Chief Medical Officer